Aktie
Zugehörige Wertpapiere Summit Therapeutics
- WKN
- A2QDFS
- ISIN
- US86627T1088
- Land
- USA 🇺🇸
- Ticker
- SMMT
- WKN
- A2QDFS
- Land
- USA 🇺🇸
- ISIN
- US86627T1088
- Ticker
- SMMT
• Nasdaq
23,700 USD
-0,720 USD-2,95 %
Geld
23,760 USD
(100 Stk.)
Brief
23,880 USD
(200 Stk.)
Tagesvolumen
2.544.988 Stk.
Tagesspanne
23,630 – 24,420 USD
52W-Spanne
11,760 – 36,910 USD
Zugehörige ETF zur Summit Therapeutics Aktie
| Name | KVG | Anteil am ETF |
|---|---|---|
iShares NASDAQ US Biotechnology UCITS ETF USD Dis. WKN A2JDYM · ISIN IE00BDZVHG35 | BlackRock | 2,10 % |
iShares NASDAQ US Biotechnology UCITS ETF USD Acc. WKN A2DWAW · ISIN IE00BYXG2H39 | BlackRock | 2,10 % |
Zugehörige Fonds zur Summit Therapeutics Aktie
| Name | KVG | Anteil am Fonds |
|---|---|---|
Protea Fund - Sectoral Biotech Opportunities Fund - IF USD ACC WKN A14NHF · ISIN LU1176839154 | Pictet | 3,02 % |
Protea Fund - Sectoral Biotech Opportunities Fund - PF USD ACC WKN A14NHG · ISIN LU1176840327 | Pictet | 3,02 % |
Protea Fund - Sectoral Biotech Opportunities Fund - IF CHF ACC H WKN A2JKJ0 · ISIN LU1711916616 | Pictet | 3,02 % |
Protea Fund - Sectoral Biotech Opportunities Fund - IF EUR ACC WKN A14NHD · ISIN LU1176837026 | Pictet | 3,02 % |
Protea Fund - Sectoral Biotech Opportunities Fund - PF EUR ACC WKN A14NHE · ISIN LU1176838347 | Pictet | 3,02 % |
Allianz Biotechnologie - R EUR DIS WKN A2AMPU · ISIN DE000A2AMPU5 | Allianz | 1,96 % |
Allianz Biotechnologie - A EUR DIS WKN 848186 · ISIN DE0008481862 | Allianz | 1,96 % |
Allianz Biotechnologie - P EUR DIS WKN A2DU17 · ISIN DE000A2DU172 | Allianz | 1,96 % |